| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |